Serbia: Wet AMD patients lack systematic access to innovative therapy

Patients in Serbia with wet age-related macular degeneration report no systematic access to innovative therapy covered by mandatory health insurance. The claim is based on patient advocacy and media reporting, with no official confirmation. This highlights a gap in healthcare access in an EU-candidate country, potentially affecting public health outcomes and policy attention.